Market Overview

Benzinga's Top Upgrades

Related AMGN
Emergent BioSolutions Gains on Trial News - Analyst Blog
Dynavax Starts Phase III Study on Heplisav-B - Analyst Blog
Amgen, GSK End Marketing Pact for Osteoporosis Drug (Fox Business)
Related PCS
U.S. Cellular Plans LTE Launch in New Markets - Analyst Blog
Reynolds Weighing Purchase of Lorillard
ObamaCare Premiums vs. Monthly Bills: Which is Higher? (Fox Business)

Piper Jaffray upgraded Amgen (NASDAQ: AMGN) from “neutral” to “overweight.” Amgen's shares closed at $79.29 yesterday. Amgen's trailing-twelve-month operating margin is 33.61%.

Deutsche Bank upgraded MetroPCS Communications (NYSE: PCS) from “hold” to “buy.” MetroPCS' stock closed at $8.59 yesterday. MetroPCS' trailing-twelve-month revenue is $4.93 billion.

Analysts at UBS upgraded Sprint Nextel (NYSE: S) from “neutral” to “buy.” Sprint's shares closed at $4.05 yesterday. Sprint had $7.57 billion in total cash for the latest quarter.

RW Baird upgraded AmerisourceBergen (NYSE: ABC) from “neutral” to “outperform.” AmerisourceBergen's shares closed at $37.96 yesterday. AmerisourceBergen's PEG ratio is 1.05.

Posted-In: top upgradesUpgrades Analyst Ratings

 

Most Popular

Related Articles (AMGN + ABC)

Around the Web, We're Loving...

Partner Network

Get Benzinga's News Delivered Free